AACR 2022: Results of a study investigating bispecific therapy AFM13 combined with natural killer cells for treatment of relapsed Hodgkin lymphoma.
Home / Resource Library / NK Cells Combined With Bispecific Antibody Induces Promising Efficacy in Advanced Lymphoma